Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$3.44
$0.05881.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 244.71% | 72.44% | 38.14% | 198.01% | 33.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 163.75% | 113.11% | 38.53% | 90.83% | 1.16% |
| Operating Income | -163.75% | -113.11% | -38.53% | -90.83% | -1.16% |
| Income Before Tax | -82.48% | -76.37% | 2.56% | -111.07% | 7.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -82.48% | -76.37% | 2.56% | -111.07% | 7.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.48% | -76.37% | 2.56% | -111.07% | 7.01% |
| EBIT | -163.75% | -113.11% | -38.53% | -90.83% | -1.16% |
| EBITDA | -163.91% | -113.33% | -38.61% | -91.00% | -1.20% |
| EPS Basic | 86.36% | 63.57% | 60.23% | -74.40% | 21.36% |
| Normalized Basic EPS | 86.43% | 62.08% | 61.49% | -42.58% | 0.93% |
| EPS Diluted | 86.36% | 63.57% | 51.08% | -74.40% | 21.36% |
| Normalized Diluted EPS | 86.43% | 62.08% | 61.49% | -42.58% | 0.93% |
| Average Basic Shares Outstanding | 1,237.41% | 384.34% | 145.01% | 21.07% | 18.26% |
| Average Diluted Shares Outstanding | 1,237.41% | 384.34% | 145.01% | 21.07% | 18.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |